mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for THRB
Gene summary
Basic gene Info.Gene symbolTHRB
Gene namethyroid hormone receptor, beta
SynonymsC-ERBA-2|C-ERBA-BETA|ERBA2|GRTH|NR1A2|PRTH|THR1|THRB1|THRB2
CytomapUCSC genome browser: 3p24.2
Type of geneprotein-coding
RefGenesNM_000461.4,
NM_001128176.2,NM_001128177.1,NM_001252634.1,
Descriptionnuclear receptor subfamily 1 group A member 2oncogene ERBA2thyroid hormone nuclear receptor beta variant 1thyroid hormone receptor betathyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian)
Modification date20141222
dbXrefs MIM : 190160
HGNC : HGNC
Ensembl : ENSG00000151090
HPRD : 07521
Vega : OTTHUMG00000130478
ProteinUniProt: P10828
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_THRB
BioGPS: 7068
PathwayNCI Pathway Interaction Database: THRB
KEGG: THRB
REACTOME: THRB
Pathway Commons: THRB
ContextiHOP: THRB
ligand binding site mutation search in PubMed: THRB
UCL Cancer Institute: THRB
Assigned class in mutLBSgeneDBA: This gene has a literature evidence and it belongs to targetable_mutLBSgenes.
References showing study about ligand binding site mutation for THRB.1. "Paragliola RM, Concolino P, De Rosa A, Mello E, Zuppi C, Pontecorvi A, Capoluongo E, Corsello SM. The first case of association between postpartum thyroiditis and thyroid hormone resistance in an Italian patient showing a novel p.V283A THRB mutation. Thyroid. 2013 Apr;23(4):506-10. doi: 10.1089/thy.2012.0080. Epub 2013 Mar 18." 23134553

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID
GO:0030522intracellular receptor signaling pathway15466465


Top
Ligand binding site mutations for THRB
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
D366D367NBRCA1
E125E125KCOAD1
R165F166YCOAD1
F451L450ICOAD1
R133T134ACOAD1
A317A317TCOAD1
L178L178MLUAD1
L178D177NLUSC1
N331G332ESKCM1
F403A402VSKCM1
R189R189SSKCM1
K188A187DSKCM1
I353A352TSTAD1
E457,F455L456SSTAD1
R158R158LSTAD1
S314S314ASTAD1
R320V319MUCEC1
I353A352VUCEC1
R196R196WUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for THRB
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
F455L456S-1.4954389
E457L456S-1.4954389
I353A352T-1.4108827
F451L450I-1.2708753
I353A352V-1.1320327
R165F166Y-1.0490555
K188A187D-1.0222338
D366D367N-1.0085977
R189R189S-0.9593743
R133T134A-0.91327819
L178L178M-0.89183666
E125E125K-0.74627277
A317A317T-0.64892699
R196R196W-0.55656254
F403A402V-0.43541837
R320V319M-0.42959768
S314S314A-0.38674892
L178D177N-0.324497
R158R158L-0.27845476
N331G332E-0.059421666
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for THRB from PDB

Top
Differential gene expression and gene-gene network for THRB
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of THRB and the right PPI network was created from samples without mutations in the LBS of THRB. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for THRB
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C2940786Thyroid Hormone Resistance Syndrome40Biomarker, GeneticVariation
umls:C2937288Thyroid Hormone Resistance, Generalized, Autosomal Dominant2Biomarker, GeneticVariation
umls:C3489796Thyroid Hormone Resistance, Generalized, Autosomal Recessive2Biomarker, GeneticVariation
umls:C0376634Craniofacial Abnormalities1Biomarker
umls:C0019284Hernia, Diaphragmatic1Biomarker

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs
27581A317TPathogenicGermlineMedGen:C2937288
OMIM:188570

Top
Pharmacological information for THRB
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
Approved|vet_approvedDB00279LiothyronineSmall molecule
ApprovedDB00451LevothyroxineSmall molecule
ApprovedDB00509DextrothyroxineSmall molecule
ApprovedDB01583LiotrixSmall molecule
ExperimentalDB02106[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic AcidSmall molecule
ExperimentalDB031763,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic AcidSmall molecule
ExperimentalDB031812-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-DioneSmall molecule
ExperimentalDB03604[4-(4-Hydroxy-3-Iodo-Phenoxy)-3,5-Diiodo-Phenyl]-Acetic AcidSmall molecule
ExperimentalDB03788GC-24Small molecule
InvestigationalDB05035KB2115Small molecule
InvestigationalDB05192MB07811Small molecule
ExperimentalDB07425{4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic acidSmall molecule
ExperimentalDB080851-(4-HEXYLPHENYL)PROP-2-EN-1-ONESmall molecule

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of THRB go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
4HY[4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID1nuoAA317 N331 I353 F455
T33,3',5-TRIIODO-L-THYRONINE1xzxXA317 N331 I353 F455
T33,3',5-TRIIODO-L-THYRONINE3gwsXA317 N331 I353 F455
B72SOBETIROME3imyAA317 N331 I353 F455
PFA[4-(4-HYDROXY-3-ISOPROPYL-PHENOXY)-3,5-DIMETHYL-PHENYL]-6-AZAURACIL1n46AA317 R320 N331 I353 F455
PFA[4-(4-HYDROXY-3-ISOPROPYL-PHENOXY)-3,5-DIMETHYL-PHENYL]-6-AZAURACIL1n46BA317 R320 N331 I353 F455
4HY[4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID1nq0AA317 R320 N331 I353 F455
4HY[4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID1nq1AA317 R320 N331 I353 F455
4HY[4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID2pinAA317 R320 N331 I353 F455
4HY[4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID2pinBA317 R320 N331 I353 F455
4HY[4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID3d57AA317 R320 N331 I353 F455
4HY[4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID3d57BA317 R320 N331 I353 F455
T33,3',5-TRIIODO-L-THYRONINE4zo1XA317 R320 N331 I353 F455
G24[4-(3-BENZYL-4-HYDROXYBENZYL)-3,5-DIMETHYLPHENOXY]ACETIC ACID1q4xAD366
IIIPeptide ligand (HIS,LYS,ILE,LEU,HIS,ARG,LEU,LEU,GLN,ASP,SER,SER)1bsxAE457
IIIPeptide ligand (HIS,LYS,ILE,LEU,HIS,ARG,LEU,LEU,GLN,ASP,SER,SER)1bsxBE457
IIIPeptide ligand (HIS,LYS,ILE,LEU,HIS,ARG,LEU,LEU)4zo1XE457
IH5[4-(4-HYDROXY-3-ISOPROPYLPHENOXY)-3,5-DIMETHYLPHENYL]ACETIC ACID1naxAN331 I353 F455
4HY[4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID1nq2AN331 I353 F455
OEF3,5-DIBROMO-4-(3-ISOPROPYL-PHENOXY)BENZOICACID2j4aAR320 I353 F455
G24[4-(3-BENZYL-4-HYDROXYBENZYL)-3,5-DIMETHYLPHENOXY]ACETIC ACID1q4xAR320 N331 F451 F455
442[3,5-DIBROMO-4-(4-HYDROXY-3-PHENETHYLCARBAMOYL-PHENOXY)-PHENYL]-ACETIC ACID1r6gAR320 N331 I353 F455
4HY[4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID3jzcAR320 N331 I353 F455
T33,3',5-TRIIODO-L-THYRONINE1bsxAS314 N331 I353 F455
T33,3',5-TRIIODO-L-THYRONINE1bsxBS314 N331 I353 F455
T44L-THYROXINE1y0xXS314 N331 I353 F455


Top
Conservation information for LBS of THRB
Multiple alignments for P10828 in multiple species
LBSAA sequence# speciesSpecies
A279KIITPAITRVV3Homo sapiens, Danio rerio, Mus musculus
A317IMSLRAAVRYD3Homo sapiens, Danio rerio, Mus musculus
C107DKDELCVVCGD3Homo sapiens, Danio rerio, Mus musculus
C110ELCVVCGDKAT3Homo sapiens, Danio rerio, Mus musculus
C124YRCITCEGCKG3Homo sapiens, Danio rerio, Mus musculus
C127ITCEGCKGFFR3Homo sapiens, Danio rerio, Mus musculus
D366SSFNLDDTEVA2Homo sapiens, Mus musculus
D366SSFNLDDSEVA1Danio rerio
E125RCITCEGCKGF3Homo sapiens, Danio rerio, Mus musculus
E457PPLFLEVFED3Homo sapiens, Danio rerio, Mus musculus
F130EGCKGFFRRTI3Homo sapiens, Danio rerio, Mus musculus
F269VDLEAFSHFTK2Homo sapiens, Mus musculus
F269VDIEAFSQFTK1Danio rerio
F272EAFSHFTKIIT2Homo sapiens, Mus musculus
F272EAFSQFTKIIT1Danio rerio
F403SFLLAFEHYIN2Homo sapiens, Mus musculus
F403EFLLAFEHYIN1Danio rerio
F439CHASRFLHMKV3Homo sapiens, Danio rerio, Mus musculus
F451CPTELFPPLFL3Homo sapiens, Danio rerio, Mus musculus
F455LFPPLFLEVFE3Homo sapiens, Danio rerio, Mus musculus
G126CITCEGCKGFF3Homo sapiens, Danio rerio, Mus musculus
G344GQLKNGGLGVV3Homo sapiens, Danio rerio, Mus musculus
G345QLKNGGLGVVS3Homo sapiens, Danio rerio, Mus musculus
H118KATGYHYRCIT3Homo sapiens, Danio rerio, Mus musculus
H435MIGACHASRFL3Homo sapiens, Danio rerio, Mus musculus
I275SHFTKIITPAI2Homo sapiens, Mus musculus
I275SQFTKIITPAI1Danio rerio
I276HFTKIITPAIT2Homo sapiens, Mus musculus
I276QFTKIITPAIT1Danio rerio
I302PCEDQIILLKG3Homo sapiens, Danio rerio, Mus musculus
I353VVSDAIFDLGM2Homo sapiens, Mus musculus
I353VVSDAIFDLGV1Danio rerio
K128TCEGCKGFFRR3Homo sapiens, Danio rerio, Mus musculus
K188SKRLAKRKLIE3Homo sapiens, Danio rerio, Mus musculus
K288VVDFAKKLPMF3Homo sapiens, Danio rerio, Mus musculus
K306QIILLKGCCME3Homo sapiens, Danio rerio, Mus musculus
L178GMATDLVLDDS3Homo sapiens, Danio rerio, Mus musculus
L180ATDLVLDDSKR3Homo sapiens, Danio rerio, Mus musculus
L330SETLTLNGEMA2Homo sapiens, Mus musculus
L330SDTLTLNGEMA1Danio rerio
L341VTRGQLKNGGL3Homo sapiens, Danio rerio, Mus musculus
L346LKNGGLGVVSD3Homo sapiens, Danio rerio, Mus musculus
L365LSSFNLDDTEV2Homo sapiens, Mus musculus
L365LSSFNLDDSEV1Danio rerio
L454ELFPPLFLEVF3Homo sapiens, Danio rerio, Mus musculus
M310LKGCCMEIMSL3Homo sapiens, Danio rerio, Mus musculus
M313CCMEIMSLRAA3Homo sapiens, Danio rerio, Mus musculus
M442SRFLHMKVECP3Homo sapiens, Danio rerio, Mus musculus
N159DKVTRNQCQEC3Homo sapiens, Danio rerio, Mus musculus
N195KLIEENREKRR2Homo sapiens, Mus musculus
N195KLIEENRERRR1Danio rerio
N331ETLTLNGEMAV2Homo sapiens, Mus musculus
N331DTLTLNGEMAV1Danio rerio
P453TELFPPLFLEV3Homo sapiens, Danio rerio, Mus musculus
Q136FRRTIQKNLHP1Homo sapiens
Q136FRRTIQKNLNP1Danio rerio
Q136FRRTIQKSLHP1Mus musculus
Q162TRNQCQECRFK3Homo sapiens, Danio rerio, Mus musculus
Q301LPCEDQIILLK3Homo sapiens, Danio rerio, Mus musculus
R132CKGFFRRTIQK3Homo sapiens, Danio rerio, Mus musculus
R133KGFFRRTIQKN2Homo sapiens, Danio rerio
R133KGFFRRTIQKS1Mus musculus
R158IDKVTRNQCQE3Homo sapiens, Danio rerio, Mus musculus
R165QCQECRFKKCI3Homo sapiens, Danio rerio, Mus musculus
R185LDDSKRLAKRK3Homo sapiens, Danio rerio, Mus musculus
R189KRLAKRKLIEE3Homo sapiens, Danio rerio, Mus musculus
R196LIEENREKRRR2Homo sapiens, Mus musculus
R196LIEENRERRRR1Danio rerio
R282TPAITRVVDFA3Homo sapiens, Danio rerio, Mus musculus
R316EIMSLRAAVRY3Homo sapiens, Danio rerio, Mus musculus
R320LRAAVRYDPES2Homo sapiens, Danio rerio
R320LRAAVRYDPDS1Mus musculus
R438ACHASRFLHMK3Homo sapiens, Danio rerio, Mus musculus
S314CMEIMSLRAAV3Homo sapiens, Danio rerio, Mus musculus
T273AFSHFTKIITP2Homo sapiens, Mus musculus
T273AFSQFTKIITP1Danio rerio
T281ITPAITRVVDF3Homo sapiens, Danio rerio, Mus musculus
T329ESETLTLNGEM1Homo sapiens
T329ESDTLTLNGEM1Danio rerio
T329DSETLTLNGEM1Mus musculus
V179MATDLVLDDSK3Homo sapiens, Danio rerio, Mus musculus
V284AITRVVDFAKK3Homo sapiens, Danio rerio, Mus musculus
V458PLFLEVFED3Homo sapiens, Danio rerio, Mus musculus
Y117DKATGYHYRCI3Homo sapiens, Danio rerio, Mus musculus
Y119ATGYHYRCITC3Homo sapiens, Danio rerio, Mus musculus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas